ADDV-B 📈 ADDvise Group B - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007464862
ADDV-B: Laboratory Equipment, Medical Furniture, Orthopedic Implants, Stents, Surgical Tables
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science research industries. It is also involved in design, construction, and installation of clean rooms. The Healthcare business unit manufactures and supplies medical equipment and consumables for healthcare and pharmaceuticals. In addition, it manufactures and sells surgical tables, as well as offers cables, connectors, and wires. Further, the company develops orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. Additionally, it sells consumable materials for ultrasound systems, and examines for urology and gynecology. ADDvise Group AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden. Web URL: https://www.addvisegroup.se
Additional Sources for ADDV-B Stock
ADDV-B Stock Overview
Market Cap in USD | 66m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception |
ADDV-B Stock Ratings
Growth 5y | 50.9% |
Fundamental | 39.0% |
Dividend | 1.0% |
Rel. Strength Industry | -3231 |
Analysts | - |
Fair Price Momentum | 2.65 SEK |
Fair Price DCF | 2.46 SEK |
ADDV-B Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 1.0% |
ADDV-B Growth Ratios
Growth Correlation 3m | -95.9% |
Growth Correlation 12m | -95.8% |
Growth Correlation 5y | 71.9% |
CAGR 5y | 35.35% |
CAGR/Mean DD 5y | 1.37 |
Sharpe Ratio 12m | -2.05 |
Alpha | -94.34 |
Beta | 0.78 |
Volatility | 57.43% |
Current Volume | 431.2k |
Average Volume 20d | 457.8k |
What is the price of ADDV-B stocks?
As of December 21, 2024, the stock is trading at SEK 3.29 with a total of 431,249 shares traded.
Over the past week, the price has changed by -10.18%, over one month by -23.30%, over three months by -56.50% and over the past year by -73.01%.
As of December 21, 2024, the stock is trading at SEK 3.29 with a total of 431,249 shares traded.
Over the past week, the price has changed by -10.18%, over one month by -23.30%, over three months by -56.50% and over the past year by -73.01%.
Is ADDvise Group B a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, ADDvise Group B (ST:ADDV-B) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.00 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADDV-B as of December 2024 is 2.65. This means that ADDV-B is currently overvalued and has a potential downside of -19.45%.
Partly, yes. Based on ValueRay Fundamental Analyses, ADDvise Group B (ST:ADDV-B) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.00 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADDV-B as of December 2024 is 2.65. This means that ADDV-B is currently overvalued and has a potential downside of -19.45%.
Is ADDV-B a buy, sell or hold?
ADDvise Group B has no consensus analysts rating.
ADDvise Group B has no consensus analysts rating.
What are the forecast for ADDV-B stock price target?
According to ValueRays Forecast Model, ADDV-B ADDvise Group B will be worth about 2.9 in December 2025. The stock is currently trading at 3.29. This means that the stock has a potential downside of -13.07%.
According to ValueRays Forecast Model, ADDV-B ADDvise Group B will be worth about 2.9 in December 2025. The stock is currently trading at 3.29. This means that the stock has a potential downside of -13.07%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 8.7 | 164.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 2.9 | -13.1% |